Show simple item record

dc.contributor.authorGürsoy, Mervi
dc.contributor.authorYilmaz, Mustafa
dc.contributor.authorDemir, Esra
dc.contributor.authorFiratli, Erhan
dc.contributor.authorGürsoy, Ulvi Kahragman
dc.date.accessioned2023-02-21T10:25:41Z
dc.date.available2023-02-21T10:25:41Z
dc.date.issued2023
dc.identifier.citationYilmaz M., Demir E., Gürsoy M., Firatli E., Gürsoy U. K., "Baseline interleukin-10, CD163 and tumor necrosis factor-like weak inducer of apoptosis gingival tissue levels in relation to clinical periodontal treatment outcomes: A 12-week follow-up study", JOURNAL OF PERIODONTOLOGY, cilt.94, sa.1, ss.141-154, 2023
dc.identifier.issn0022-3492
dc.identifier.otherav_43d038c6-0bc9-4575-8230-59947d008a0e
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/188394
dc.identifier.urihttps://doi.org/10.1002/jper.22-0242
dc.description.abstractBackground The aim of this study was to examine the relationship between healing response after non-surgical periodontal treatment and baseline gingival tissue levels of M2 macrophage activation-related proteins CD163, interleukin (IL)-10, interferon (IFN)-gamma, and tumor necrosis factor-like weak inducer of apoptosis (TWEAK), and the CD163/TWEAK ratio. Methods Eighty-eight gingival tissue samples from 44 Stage III/IV, Grade C periodontitis patients (18 smokers) and 41 tissue samples from 41 periodontally healthy participants (18 smokers) were evaluated. Clinical parameters were recorded in periodontally healthy individuals at baseline and in periodontitis patients at pre-treatment and 2, 6, and 12 weeks following therapy. IL-10, IFN-gamma, CD163, and TWEAK levels were analyzed with Luminex technique. Results Tissue levels (median, 1(st)-3(rd) quartile) of IL-10 (pg/ng protein), CD163 (pg/mu g protein) and TWEAK (pg/mu g protein) were as follows: IL-10 periodontitis: 2.08, 0.86-5.32 and periodontally healthy: 5.22, 3.20-10.25; CD163 periodontitis: 8.85, 4.92-14.06 and periodontally healthy: 18.36, 12.51-34.02; TWEAK periodontitis: 0.08, 0.05-0.11 and periodontally healthy: 0.16, 0.12-0.21. IL-10, CD163, and TWEAK levels were higher (P < 0.001) in periodontally healthy tissues than in periodontitis tissues. Pocket closure at 12 weeks was associated with elevated baseline gingival CD163 levels (P = 0.047) and CD163/TWEAK ratio (P = 0.001). Elevated baseline gingival CD163/TWEAK ratio was associated with pocket reduction at 6 (P = 0.022) and 12 weeks (P = 0.002). Conclusion Associations of pocket closure with pre-treatment gingival tissue CD163 levels and CD163/TWEAK ratio indicate that baseline M2 macrophage activation profile may play a role in periodontal wound healing.
dc.language.isoeng
dc.subjectDiş Hekimliği
dc.subjectDİŞ HEKİMLİĞİ, ORAL CERRAHİ VE TIP
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectPeriodontoloji
dc.subjectOrtodonti
dc.subjectAğız Cerrahisi
dc.subjectDiş Hijyeni
dc.subjectDişçilik Hizmetleri
dc.subjectDiş Hekimliği (çeşitli)
dc.titleBaseline interleukin-10, CD163 and tumor necrosis factor-like weak inducer of apoptosis gingival tissue levels in relation to clinical periodontal treatment outcomes: A 12-week follow-up study
dc.typeMakale
dc.relation.journalJOURNAL OF PERIODONTOLOGY
dc.contributor.department, ,
dc.identifier.volume94
dc.identifier.issue1
dc.identifier.startpage141
dc.identifier.endpage154
dc.contributor.firstauthorID3435970


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record